← Ишга қайтиш
Ушбу иш иқтибос қилган ишлар
105 та иш
Иш: Trogocytosis in cancer immunity and cellular immunotherapy: mechanisms, therapeutic challenges, and translational opportunities
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Enli Liu, David Marín, Pinaki P. Banerjee +24
Мақола20206 иқтибосABIAnti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
Noopur Raje, Jesús G. Berdeja, Yi Lin +20
Мақола20194 иқтибосABICAR-T cell therapy for cancer: current challenges and future directions
Inés Zugasti, Lady Espinosa-Aroca, Klaudyna Fidyt +7
Шарҳ мақола20254 иқтибосABINon-viral chimeric antigen receptor (CAR) T cells going viral
Hyatt Balke‐Want, Vimal Keerthi, Amaia Cadiñanos-Garai +6
Шарҳ мақола20232 иқтибосABITrogocytosis of CAR molecule regulates CAR-T cell dysfunction and tumor antigen escape
You Zhai, Yicong Du, Guanzhang Li +9
Мақола20232 иқтибосABITrogocytosis-mediated immune evasion in the tumor microenvironment
Jeonghyun Kim, So Yeon Park, Jungseo Kim +6
Шарҳ мақола20252 иқтибосABINeutrophils Kill Antibody-Opsonized Cancer Cells by Trogoptosis
Hanke L. Matlung, Liane Babes, Xi Zhao +26
Мақола20182 иқтибосABIThe landscape of CAR-engineered innate immune cells for cancer immunotherapy
Ourania Tsahouridis, Max Xu, Feifei Song +2
Шарҳ мақола20252 иқтибосABI